25 XP   0   0   10

Chromadex Corp
Buy, Hold or Sell?

Let's analyse Chromadex together

PenkeI guess you are interested in Chromadex Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chromadex Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chromadex Corp

I send you an email if I find something interesting about Chromadex Corp.

Quick analysis of Chromadex (30 sec.)










What can you expect buying and holding a share of Chromadex? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.38
Expected worth in 1 year
$0.37
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-0.3%

For what price can you sell your share?

Current Price per Share
$3.76
Expected price per share
$2.28 - $4.65
How sure are you?
50%

1. Valuation of Chromadex (5 min.)




Live pricePrice per Share (EOD)

$3.76

Intrinsic Value Per Share

$-0.73 - $2.26

Total Value Per Share

$-0.35 - $2.64

2. Growth of Chromadex (5 min.)




Is Chromadex growing?

Current yearPrevious yearGrowGrow %
How rich?$28.4m$28.6m-$216k-0.8%

How much money is Chromadex making?

Current yearPrevious yearGrowGrow %
Making money-$4.9m-$14.4m$9.5m192.6%
Net Profit Margin-5.9%-20.1%--

How much money comes from the company's main activities?

3. Financial Health of Chromadex (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#527 / 1007

Most Revenue
#221 / 1007

Most Profit
#244 / 1007

Most Efficient
#442 / 1007

What can you expect buying and holding a share of Chromadex? (5 min.)

Welcome investor! Chromadex's management wants to use your money to grow the business. In return you get a share of Chromadex.

What can you expect buying and holding a share of Chromadex?

First you should know what it really means to hold a share of Chromadex. And how you can make/lose money.

Speculation

The Price per Share of Chromadex is $3.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chromadex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chromadex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.38. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chromadex.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-1.7%-0.07-1.7%-0.22-5.8%-0.27-7.1%-0.21-5.5%
Usd Book Value Change Per Share0.00-0.1%0.00-0.1%-0.04-1.1%0.000.1%0.030.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.1%0.00-0.1%-0.04-1.1%0.000.1%0.030.8%
Usd Price Per Share1.43-1.43-1.68-3.19-3.07-
Price to Earnings Ratio-21.87--21.87--7.67--13.65--24.60-
Price-to-Total Gains Ratio-500.00--500.00--41.53--132.31--57.57-
Price to Book Ratio3.80-3.80-4.43-11.02-13.21-
Price-to-Total Gains Ratio-500.00--500.00--41.53--132.31--57.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.76
Number of shares265
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (265 shares)-0.760.90
Gains per Year (265 shares)-3.033.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3-1304-6
20-6-1607-2
30-9-190112
40-12-220146
50-15-2501810
60-18-2802214
70-21-3102518
80-24-3402922
90-27-3703226
100-30-4003630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%9.08.00.052.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.017.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%9.08.00.052.9%

Fundamentals of Chromadex

About Chromadex Corp

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Fundamental data was last updated by Penke on 2024-05-02 13:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Chromadex Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chromadex earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • A Net Profit Margin of -5.9% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chromadex Corp:

  • The MRQ is -5.9%. The company is making a loss. -1
  • The TTM is -5.9%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-5.9%0.0%
TTM-5.9%YOY-20.1%+14.1%
TTM-5.9%5Y-32.6%+26.7%
5Y-32.6%10Y-38.1%+5.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.9%-207.2%+201.3%
TTM-5.9%-218.5%+212.6%
YOY-20.1%-282.4%+262.3%
5Y-32.6%-432.2%+399.6%
10Y-38.1%-593.8%+555.7%
1.1.2. Return on Assets

Shows how efficient Chromadex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • -9.0% Return on Assets means that Chromadex generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chromadex Corp:

  • The MRQ is -9.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.0%TTM-9.0%0.0%
TTM-9.0%YOY-26.7%+17.7%
TTM-9.0%5Y-41.3%+32.3%
5Y-41.3%10Y-37.9%-3.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.0%-13.2%+4.2%
TTM-9.0%-12.6%+3.6%
YOY-26.7%-11.5%-15.2%
5Y-41.3%-13.7%-27.6%
10Y-37.9%-15.5%-22.4%
1.1.3. Return on Equity

Shows how efficient Chromadex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • -17.4% Return on Equity means Chromadex generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chromadex Corp:

  • The MRQ is -17.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.4%TTM-17.4%0.0%
TTM-17.4%YOY-50.4%+33.0%
TTM-17.4%5Y-83.0%+65.6%
5Y-83.0%10Y-77.5%-5.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.4%-16.7%-0.7%
TTM-17.4%-15.8%-1.6%
YOY-50.4%-14.4%-36.0%
5Y-83.0%-19.0%-64.0%
10Y-77.5%-19.9%-57.6%

1.2. Operating Efficiency of Chromadex Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chromadex is operating .

  • Measures how much profit Chromadex makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • An Operating Margin of -2.3% means the company generated $-0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chromadex Corp:

  • The MRQ is -2.3%. The company is operating very inefficient. -2
  • The TTM is -2.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2.3%0.0%
TTM-2.3%YOY-25.9%+23.6%
TTM-2.3%5Y-33.9%+31.6%
5Y-33.9%10Y-40.6%+6.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%-286.5%+284.2%
TTM-2.3%-229.1%+226.8%
YOY-25.9%-288.4%+262.5%
5Y-33.9%-480.7%+446.8%
10Y-40.6%-624.7%+584.1%
1.2.2. Operating Ratio

Measures how efficient Chromadex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are $1.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Chromadex Corp:

  • The MRQ is 1.023. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.023. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.023TTM1.0230.000
TTM1.023YOY1.259-0.236
TTM1.0235Y1.339-0.316
5Y1.33910Y1.404-0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0233.231-2.208
TTM1.0233.307-2.284
YOY1.2593.774-2.515
5Y1.3395.667-4.328
10Y1.4047.558-6.154

1.3. Liquidity of Chromadex Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chromadex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.40 means the company has $2.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Chromadex Corp:

  • The MRQ is 2.402. The company is able to pay all its short-term debts. +1
  • The TTM is 2.402. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.402TTM2.4020.000
TTM2.402YOY2.606-0.204
TTM2.4025Y2.393+0.009
5Y2.39310Y2.705-0.312
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4023.890-1.488
TTM2.4024.182-1.780
YOY2.6065.343-2.737
5Y2.3936.135-3.742
10Y2.7056.453-3.748
1.3.2. Quick Ratio

Measures if Chromadex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • A Quick Ratio of 1.58 means the company can pay off $1.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chromadex Corp:

  • The MRQ is 1.579. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.579. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.579TTM1.5790.000
TTM1.579YOY1.607-0.029
TTM1.5795Y1.526+0.052
5Y1.52610Y1.863-0.337
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5793.528-1.949
TTM1.5794.059-2.480
YOY1.6075.390-3.783
5Y1.5266.138-4.612
10Y1.8636.488-4.625

1.4. Solvency of Chromadex Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chromadex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chromadex to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.48 means that Chromadex assets are financed with 48.2% credit (debt) and the remaining percentage (100% - 48.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chromadex Corp:

  • The MRQ is 0.482. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.482. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.482TTM0.4820.000
TTM0.482YOY0.470+0.013
TTM0.4825Y0.493-0.011
5Y0.49310Y0.483+0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4820.339+0.143
TTM0.4820.337+0.145
YOY0.4700.273+0.197
5Y0.4930.368+0.125
10Y0.4830.391+0.092
1.4.2. Debt to Equity Ratio

Measures if Chromadex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • A Debt to Equity ratio of 93.2% means that company has $0.93 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chromadex Corp:

  • The MRQ is 0.932. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.932. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.932TTM0.9320.000
TTM0.932YOY0.885+0.046
TTM0.9325Y0.989-0.057
5Y0.98910Y1.110-0.121
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9320.388+0.544
TTM0.9320.403+0.529
YOY0.8850.342+0.543
5Y0.9890.432+0.557
10Y1.1100.461+0.649

2. Market Valuation of Chromadex Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Chromadex generates.

  • Above 15 is considered overpriced but always compare Chromadex to the Biotechnology industry mean.
  • A PE ratio of -21.87 means the investor is paying $-21.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chromadex Corp:

  • The EOD is -57.507. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.871. Based on the earnings, the company is expensive. -2
  • The TTM is -21.871. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-57.507MRQ-21.871-35.636
MRQ-21.871TTM-21.8710.000
TTM-21.871YOY-7.671-14.200
TTM-21.8715Y-13.655-8.216
5Y-13.65510Y-24.605+10.950
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-57.507-2.249-55.258
MRQ-21.871-2.553-19.318
TTM-21.871-2.669-19.202
YOY-7.671-4.107-3.564
5Y-13.655-6.247-7.408
10Y-24.605-6.499-18.106
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chromadex Corp:

  • The EOD is 41.191. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 15.666. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 15.666. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD41.191MRQ15.666+25.525
MRQ15.666TTM15.6660.000
TTM15.666YOY-8.222+23.888
TTM15.6665Y-10.632+26.297
5Y-10.63210Y-21.507+10.875
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD41.191-2.858+44.049
MRQ15.666-3.288+18.954
TTM15.666-3.552+19.218
YOY-8.222-5.560-2.662
5Y-10.632-8.326-2.306
10Y-21.507-8.881-12.626
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chromadex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.80 means the investor is paying $3.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Chromadex Corp:

  • The EOD is 9.979. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.795. Based on the equity, the company is fair priced.
  • The TTM is 3.795. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD9.979MRQ3.795+6.184
MRQ3.795TTM3.7950.000
TTM3.795YOY4.425-0.630
TTM3.7955Y11.023-7.228
5Y11.02310Y13.207-2.184
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.9791.929+8.050
MRQ3.7952.090+1.705
TTM3.7952.091+1.704
YOY4.4252.881+1.544
5Y11.0233.545+7.478
10Y13.2073.936+9.271
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Chromadex Corp.

3.1. Institutions holding Chromadex Corp

Institutions are holding 16.068% of the shares of Chromadex Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc4.04750.0001304811944770.1471
2023-12-31Tieton Capital Management, LLC3.8692.3472291367546169218.8293
2023-12-31ICONIQ Capital, LLC1.72140.0346129635400
2023-12-31BlackRock Inc1.20130904692-2809-0.3095
2023-12-31Geode Capital Management, LLC0.66920.000150394300
2023-12-31Renaissance Technologies Corp0.62320.001469302243905.482
2023-12-31Gamco Investors, Inc. Et Al0.34740.00426165018000.6927
2023-12-31Gabelli Funds LLC0.26560.00222000002000011.1111
2023-12-31State Street Corporation0.2526019023900
2023-09-30Citadel Advisors Llc0.22940.0001172770-14443-7.7147
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC0.19790.0054149035101227.2866
2023-12-31Qube Research & Technologies0.1750.0004131794119184945.1546
2023-12-31Millennium Management LLC0.16610.0001125096-105601-45.7748
2023-12-31Royal Bank of Canada0.158101190423444840.7216
2023-12-31CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.15640.0007117790-5128-4.1719
2023-12-31Connor Clark & Lunn Inv Mgmt Ltd0.15470.00081165133348240.3247
2023-12-31Northern Trust Corp0.124909408400
2023-12-31Bank of New York Mellon Corp0.1144086147-239-0.2767
2023-12-31Silverberg Bernstein Capital Management LLC0.10990.112982757827570
2023-12-31Squarepoint Ops LLC0.08220.00026189936326.2334
Total 14.66622.509811044901+667764+6.0%

3.2. Funds holding Chromadex Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Tieton Small Cap Value3.8692.2995291367546169218.8293
2024-02-29Vanguard Total Stock Mkt Idx Inv2.91660.0002219648400
2023-12-31Pleiades Small Cap Equity A1.10250.131983030015419022.8055
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.9930.002574781400
2024-02-29PA Ucits Food Revolution S USD0.41220.87383104007586632.3475
2024-02-29Fidelity Extended Market Index0.36010.0012271180-1314-0.4822
2023-12-31Acuitas US Microcap Institutional0.27590.4342077804054024.2406
2023-12-31Gabelli Equity Trust0.17260.00941300002000018.1818
2024-03-28iShares Micro-Cap ETF0.15550.044311710923142.0158
2023-09-30BlackRock Extended Mkt Composite0.1480.001211145700
2024-03-31GAMCO Small Cap Value0.13280.63410000000
2024-03-31BlackRock Extended Equity Market K0.12920.002397272350.036
2024-02-29Fidelity Total Market Index0.1080.00028132900
2023-12-31Gabelli Global Small & Mid Cap Value Tru0.0930.07577000000
2024-02-29Fidelity Series Total Market Index0.09050.00026813600
2024-03-31NT Ext Equity Mkt Idx Fd - L0.06720.002850592748717.3692
2024-03-31Vanguard Balanced Index Inv0.06290.00034740300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06120.0014612500
2023-12-31Northern Trust Extended Eq Market Idx0.05720.00114310500
2024-02-29Fidelity Nasdaq Composite Index0.05640.00054249500
Total 11.26384.51618482656+760810+9.0%

3.3. Insider Transactions

Insiders are holding 35.794% of the shares of Chromadex Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-01Brianna GerberBUY50001.41
2023-06-12Frank L Jaksch JrBUY70001.69
2023-05-31Robert N FriedBUY70001.42
2023-05-25Steven D RubinBUY70001.46

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Chromadex Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%-0.040+1314%0.003-185%0.030-109%
Book Value Per Share--0.3770.3770%0.380-1%0.333+13%0.299+26%
Current Ratio--2.4022.4020%2.606-8%2.393+0%2.705-11%
Debt To Asset Ratio--0.4820.4820%0.470+3%0.493-2%0.4830%
Debt To Equity Ratio--0.9320.9320%0.885+5%0.989-6%1.110-16%
Dividend Per Share----0%-0%-0%-0%
Eps---0.065-0.0650%-0.219+235%-0.267+308%-0.207+217%
Free Cash Flow Per Share--0.0910.0910%-0.204+324%-0.172+289%-0.144+258%
Free Cash Flow To Equity Per Share--0.0910.0910%-0.103+213%0.011+714%0.023+302%
Gross Profit Margin--6.3546.3540%2.960+115%3.027+110%2.303+176%
Intrinsic Value_10Y_max--2.261--------
Intrinsic Value_10Y_min---0.728--------
Intrinsic Value_1Y_max---0.064--------
Intrinsic Value_1Y_min---0.149--------
Intrinsic Value_3Y_max--0.028--------
Intrinsic Value_3Y_min---0.384--------
Intrinsic Value_5Y_max--0.389--------
Intrinsic Value_5Y_min---0.548--------
Market Cap283969488.000+62%107999034.000107999034.0000%126879984.000-15%241071969.600-55%231714570.780-53%
Net Profit Margin---0.059-0.0590%-0.201+239%-0.326+452%-0.381+545%
Operating Margin---0.023-0.0230%-0.259+1038%-0.339+1391%-0.406+1685%
Operating Ratio--1.0231.0230%1.259-19%1.339-24%1.404-27%
Pb Ratio9.979+62%3.7953.7950%4.425-14%11.023-66%13.207-71%
Pe Ratio-57.507-163%-21.871-21.8710%-7.671-65%-13.655-38%-24.605+13%
Price Per Share3.760+62%1.4301.4300%1.680-15%3.192-55%3.068-53%
Price To Free Cash Flow Ratio41.191+62%15.66615.6660%-8.222+152%-10.632+168%-21.507+237%
Price To Total Gains Ratio-1314.674-163%-499.996-499.9960%-41.532-92%-132.314-74%-57.569-88%
Quick Ratio--1.5791.5790%1.607-2%1.526+3%1.863-15%
Return On Assets---0.090-0.0900%-0.267+198%-0.413+359%-0.379+322%
Return On Equity---0.174-0.1740%-0.504+190%-0.830+378%-0.775+347%
Total Gains Per Share---0.003-0.0030%-0.040+1314%0.003-185%0.030-109%
Usd Book Value--28456000.00028456000.0000%28672000.000-1%25144800.000+13%22598309.100+26%
Usd Book Value Change Per Share---0.003-0.0030%-0.040+1314%0.003-185%0.030-109%
Usd Book Value Per Share--0.3770.3770%0.380-1%0.333+13%0.299+26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.065-0.0650%-0.219+235%-0.267+308%-0.207+217%
Usd Free Cash Flow--6894000.0006894000.0000%-15432000.000+324%-13008800.000+289%-10881217.500+258%
Usd Free Cash Flow Per Share--0.0910.0910%-0.204+324%-0.172+289%-0.144+258%
Usd Free Cash Flow To Equity Per Share--0.0910.0910%-0.103+213%0.011+714%0.023+302%
Usd Market Cap283969488.000+62%107999034.000107999034.0000%126879984.000-15%241071969.600-55%231714570.780-53%
Usd Price Per Share3.760+62%1.4301.4300%1.680-15%3.192-55%3.068-53%
Usd Profit---4938000.000-4938000.0000%-14449000.000+193%-18979600.000+284%-15067905.500+205%
Usd Revenue--83570000.00083570000.0000%72050000.000+16%65723400.000+27%44551388.700+88%
Usd Total Gains Per Share---0.003-0.0030%-0.040+1314%0.003-185%0.030-109%
 EOD+4 -4MRQTTM+0 -0YOY+22 -125Y+25 -910Y+22 -12

4.2. Fundamental Score

Let's check the fundamental score of Chromadex Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-57.507
Price to Book Ratio (EOD)Between0-19.979
Net Profit Margin (MRQ)Greater than0-0.059
Operating Margin (MRQ)Greater than0-0.023
Quick Ratio (MRQ)Greater than11.579
Current Ratio (MRQ)Greater than12.402
Debt to Asset Ratio (MRQ)Less than10.482
Debt to Equity Ratio (MRQ)Less than10.932
Return on Equity (MRQ)Greater than0.15-0.174
Return on Assets (MRQ)Greater than0.05-0.090
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Chromadex Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.986
Ma 20Greater thanMa 503.725
Ma 50Greater thanMa 1003.008
Ma 100Greater thanMa 2002.239
OpenGreater thanClose3.690
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets54,964
Total Liabilities26,508
Total Stockholder Equity28,456
 As reported
Total Liabilities 26,508
Total Stockholder Equity+ 28,456
Total Assets = 54,964

Assets

Total Assets54,964
Total Current Assets49,534
Long-term Assets5,430
Total Current Assets
Cash And Cash Equivalents 27,325
Net Receivables 5,234
Inventory 14,525
Other Current Assets 2,450
Total Current Assets  (as reported)49,534
Total Current Assets  (calculated)49,534
+/-0
Long-term Assets
Property Plant Equipment 4,537
Intangible Assets 510
Long-term Assets Other 383
Long-term Assets  (as reported)5,430
Long-term Assets  (calculated)5,430
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities20,622
Long-term Liabilities5,886
Total Stockholder Equity28,456
Total Current Liabilities
Short-term Debt 702
Accounts payable 10,232
Other Current Liabilities 9,493
Total Current Liabilities  (as reported)20,622
Total Current Liabilities  (calculated)20,427
+/- 195
Long-term Liabilities
Capital Lease Obligations 3,277
Long-term Liabilities  (as reported)5,886
Long-term Liabilities  (calculated)3,277
+/- 2,609
Total Stockholder Equity
Common Stock75
Retained Earnings -190,460
Accumulated Other Comprehensive Income -4
Other Stockholders Equity 218,845
Total Stockholder Equity (as reported)28,456
Total Stockholder Equity (calculated)28,456
+/-0
Other
Capital Stock75
Cash and Short Term Investments 27,325
Common Stock Shares Outstanding 74,985
Current Deferred Revenue195
Liabilities and Stockholders Equity 54,964
Net Debt -24,048
Net Invested Capital 28,456
Net Working Capital 28,912
Property Plant and Equipment Gross 9,947
Short Long Term Debt Total 3,277



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
1
4,083
3,565
6,507
6,270
9,035
8,987
11,608
18,749
19,752
62,724
42,232
40,247
38,358
57,840
54,057
54,964
54,96454,05757,84038,35840,24742,23262,72419,75218,74911,6088,9879,0356,2706,5073,5654,0831
   > Total Current Assets 
1
2,299
2,008
4,895
4,953
7,927
5,791
9,899
16,548
15,737
57,178
36,534
33,518
32,219
48,905
46,567
49,534
49,53446,56748,90532,21933,51836,53457,17815,73716,5489,8995,7917,9274,9534,8952,0082,2991
       Cash And Cash Equivalents 
1
1,126
471
2,226
420
520
2,261
3,965
5,550
1,642
45,389
22,616
18,812
16,497
28,019
20,241
27,325
27,32520,24128,01916,49718,81222,61645,3891,6425,5503,9652,2615204202,2264711,1261
       Net Receivables 
380
349
498
1,002
724
1,941
1,054
1,907
2,451
5,852
5,338
4,415
2,175
2,694
5,226
8,482
5,234
5,2348,4825,2262,6942,1754,4155,3385,8522,4511,9071,0541,9417241,002498349380
       Other Current Assets 
0
113
116
244
904
261
271
293
374
330
655
577
996
1,145
1,859
2,967
2,450
2,4502,9671,8591,1459965776553303742932712619042441161130
   > Long-term Assets 
1,680
1,784
1,557
1,612
1,317
1,107
3,196
1,710
2,202
4,015
5,545
5,698
6,729
6,139
8,935
7,490
5,430
5,4307,4908,9356,1396,7295,6985,5454,0152,2021,7103,1961,1071,3171,6121,5571,7841,680
       Property Plant Equipment 
1,130
1,294
1,203
1,303
1,172
936
1,063
1,265
1,789
3,111
2,872
3,585
4,656
4,432
7,355
6,322
4,537
4,5376,3227,3554,4324,6563,5852,8723,1111,7891,2651,0639361,1721,3031,2031,2941,130
       Long Term Investments 
0
0
0
0
0
0
0
20
20
20
0
0
0
0
0
0
0
00000002020200000000
       Intangible Assets 
490
445
321
278
100
136
202
296
354
486
1,651
1,547
1,311
1,082
857
671
510
5106718571,0821,3111,5471,651486354296202136100278321445490
       Long-term Assets Other 
60
45
32
31
44
35
43
149
59
397
1,022
566
762
625
723
497
383
3834977236257625661,0223975914943354431324560
> Total Liabilities 
0
2,334
2,518
1,571
3,709
5,041
3,321
7,610
13,475
9,778
8,890
15,054
19,802
21,934
26,113
25,385
26,508
26,50825,38526,11321,93419,80215,0548,8909,77813,4757,6103,3215,0413,7091,5712,5182,3340
   > Total Current Liabilities 
0
2,073
2,152
1,139
3,343
4,763
2,838
4,981
9,587
8,869
8,088
14,440
15,063
16,476
17,613
17,869
20,622
20,62217,86917,61316,47615,06314,4408,0888,8699,5874,9812,8384,7633,3431,1392,1522,0730
       Short-term Debt 
0
78
28
79
77
77
139
372
1,748
255
196
173
853
620
548
696
702
7026965486208531731962551,74837213977777928780
       Short Long Term Debt 
0
0
0
0
0
0
0
223
1,529
0
506
0
0
0
0
0
0
00000050601,5292230000000
       Accounts payable 
0
444
548
515
2,250
3,428
1,441
3,452
6,224
5,978
3,718
9,548
9,626
9,445
10,423
9,679
10,232
10,2329,67910,4239,4459,6269,5483,7185,9786,2243,4521,4413,4282,2505155484440
       Other Current Liabilities 
0
1,516
1,448
371
816
947
712
923
1,342
2,246
3,860
4,444
4,415
6,133
6,481
7,337
9,493
9,4937,3376,4816,1334,4154,4443,8602,2461,3429237129478163711,4481,5160
   > Long-term Liabilities 
0
261
366
432
366
278
483
2,629
3,888
909
802
614
4,739
5,458
8,500
7,516
5,886
5,8867,5168,5005,4584,7396148029093,8882,6294832783664323662610
       Long term Debt Total 
0
0
0
0
0
148
280
2,491
3,790
344
310
137
18
0
0
0
0
0000181373103443,7902,49128014800000
       Other Liabilities 
0
0
0
234
201
130
203
138
98
565
492
477
3,873
4,441
4,346
3,955
0
03,9554,3464,4413,87347749256598138203130201234000
       Deferred Long Term Liability 
0
0
0
0
0
130
203
138
98
380
492
477
3,873
0
0
0
0
00003,8734774923809813820313000000
> Total Stockholder Equity
0
1,749
1,047
4,936
2,561
3,993
5,665
3,998
5,275
9,974
53,834
27,178
20,445
16,424
31,727
28,672
28,456
28,45628,67231,72716,42420,44527,17853,8349,9745,2753,9985,6653,9932,5614,9361,0471,7490
   Common Stock
1
29
29
61
73
92
105
105
108
38
55
55
60
62
68
74
75
757468626055553810810510592736129291
   Retained Earnings -190,460-185,493-168,953-141,825-121,900-89,753-56,601-45,224-42,295-39,524-34,136-29,717-18,054-10,159-8,108-7,200-40
   Capital Surplus 
0
0
0
0
0
33,618
39,697
43,417
47,462
55,160
110,380
116,876
142,285
158,190
200,614
214,094
0
0214,094200,614158,190142,285116,876110,38055,16047,46243,41739,69733,61800000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
39
8,920
10,636
16,795
20,543
36,018
42,347
46,219
50,372
58,302
111,826
118,927
142,285
158,190
200,614
214,094
218,845
218,845214,094200,614158,190142,285118,927111,82658,30250,37246,21942,34736,01820,54316,79510,6368,92039



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue83,570
Cost of Revenue-32,790
Gross Profit50,78050,780
 
Operating Income (+$)
Gross Profit50,780
Operating Expense-52,679
Operating Income-1,899-1,899
 
Operating Expense (+$)
Research Development4,958
Selling General Administrative24,983
Selling And Marketing Expenses26,438
Operating Expense52,67956,379
 
Net Interest Income (+$)
Interest Income661
Interest Expense-0
Other Finance Cost-256
Net Interest Income405
 
Pretax Income (+$)
Operating Income-1,899
Net Interest Income405
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,9381,140
EBIT - interestExpense = -1,899
-4,938
-4,938
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-1,899-4,938
Earnings Before Interest and Taxes (EBITDA)-194
 
After tax Income (+$)
Income Before Tax-4,938
Tax Provision-0
Net Income From Continuing Ops-6,470-4,938
Net Income-4,938
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses85,469
Total Other Income/Expenses Net-3,039-405
 

Technical Analysis of Chromadex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chromadex. The general trend of Chromadex is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chromadex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chromadex Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.65.

The bearish price targets are: 2.89 > 2.37 > 2.28.

Tweet this
Chromadex Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chromadex Corp. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chromadex Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chromadex Corp. The current macd is 0.10456189.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chromadex price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Chromadex. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Chromadex price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Chromadex Corp Daily Moving Average Convergence/Divergence (MACD) ChartChromadex Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chromadex Corp. The current adx is 23.57.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Chromadex shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Chromadex Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chromadex Corp. The current sar is 4.14464076.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Chromadex Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chromadex Corp. The current rsi is 56.99. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Chromadex Corp Daily Relative Strength Index (RSI) ChartChromadex Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chromadex Corp. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chromadex price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Chromadex Corp Daily Stochastic Oscillator ChartChromadex Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chromadex Corp. The current cci is 0.02657066.

Chromadex Corp Daily Commodity Channel Index (CCI) ChartChromadex Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chromadex Corp. The current cmo is 14.91.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Chromadex Corp Daily Chande Momentum Oscillator (CMO) ChartChromadex Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chromadex Corp. The current willr is -32.55813953.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Chromadex is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Chromadex Corp Daily Williams %R ChartChromadex Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chromadex Corp.

Chromadex Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chromadex Corp. The current atr is 0.32046378.

Chromadex Corp Daily Average True Range (ATR) ChartChromadex Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chromadex Corp. The current obv is 1,162,911.

Chromadex Corp Daily On-Balance Volume (OBV) ChartChromadex Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chromadex Corp. The current mfi is 56.85.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Chromadex Corp Daily Money Flow Index (MFI) ChartChromadex Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chromadex Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Chromadex Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chromadex Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.986
Ma 20Greater thanMa 503.725
Ma 50Greater thanMa 1003.008
Ma 100Greater thanMa 2002.239
OpenGreater thanClose3.690
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chromadex with someone you think should read this too:
  • Are you bullish or bearish on Chromadex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chromadex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chromadex Corp

I send you an email if I find something interesting about Chromadex Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Chromadex Corp.

Receive notifications about Chromadex Corp in your mailbox!